Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation

Molecular Genetics and Metabolism

Volumn 98, Issue 3, 2009, Pages 255-263

  Araya, Ken ^a   Sakai, Norio ^a   Mohri, Ikuko ^a   Kagitani Shimono, Kuriko ^a   Okinaga, Takeshi ^a   Hashii, Yoshiko ^a   Ohta, Hideaki ^a   Nakamichi, Itsuko ^a   Aozasa, Katsuyuki ^a   Taniike, Masako ^a   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cord blood stem cell transplantation; Hunter disease; Iduronate 2 sulfatase; Immunohistochemistry; Mucopolysaccharidosis II; Neuropathology

Indexed keywords

CD68 ANTIGEN;

ARTICLE; AUTOPSY; BRAIN; CASE REPORT; CAUSE OF DEATH; CELLULAR DISTRIBUTION; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; DONOR; ENZYME ACTIVITY; FOLLOW UP; HUMAN; HUMAN TISSUE; HUNTER SYNDROME; HYPERACTIVITY; IMMUNOREACTIVITY; KUPFFER CELL; LIVER; LIVER CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; MICROGLIA; MONOCYTE; NERVE CELL; NEUROIMAGING; OLIGODENDROGLIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL; TANDEM REPEAT; THERAPY EFFECT;

BRAIN; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSIS II; TISSUE DONORS;

EID: 70349728397     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.05.006     Document Type: Article

References (47)

1. Hunter C. A rare disease in two brothers. Proc. R. Soc. Med. 10 (1917) 104-116 (Sect Study Dis Child)
2. R.D. Lillie, H.M. Fullmer, Polysaccharides; Mucins, in: Histopathologic Technic and Practical Histochemistry, fourth ed., McGraw-Hill, New York, 1976, pp. 611-678.
3. Suzuki K., and Suzuki K. Lysosomal diseases. In: Love S., Louis D.N., and Ellison D.W. (Eds). Greenfield's Neuropathology, vol. I. eighth ed. (2008), Hodder Arnold, London 515-599
4. Nagashima K., Endo H., Sakakibara K., Konishi Y., Miyachi K., Wey J.J., Suzuki Y., and Onisawa J. Morphological and biochemical studies of a case of mucopolysaccharidosis II (Hunter's syndrome). Acta Pathol. Jpn. 26 (1976) 115-132
5. Kurihara M., Kumagai K., Goto K., Imai M., and Yagishita S. Severe type Hunter's syndrome. Polysomnographic and neuropathological study. Neuropediatrics 23 (1992) 248-256
6. Hale C.W. Histochemical demonstration of acid polysaccharides in animal tissues. Nature 157 (1946) 802
7. Portmann B.C., Thompson R.J., Roberts E.A., and Paterson A.C. Genetic and metabolic liver disease. In: Burt A.D., Portmann B.C., and Ferrell L.D. (Eds). MacSween's Pathology of the Liver. fifth ed. (2007), Churchill Livingstone, Philadelphia 199-326
8. Neufeld E., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic & Molecular Bases of Inherited Disease, vol. III. eighth ed. (2001), McGraw-Hill, New York 3421-3452
9. Wraith J.E., Scarpa M., Beck M., Bodamer O.A., De Meirleir L., Guffon N., Meldgaard Lund A., Malm G., Van der Ploeg A.T., and Zeman J. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur. J. Pediatr. 167 (2008) 267-277
10. Prasad V.K., and Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 41 (2008) 99-108
11. Fratantoni J.C., Hall C.W., and Neufeld E.F. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 162 (1968) 570-572
12. Walkley S.U., Thrall M.A., Dobrenis K., Huang M., March P.A., Siegel D.A., and Wurzelmann S. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc. Natl. Acad. Sci. USA 91 (1994) 2970-2974
13. Ellinwood N.M., Colle M.A., Weil M.A., Casal M.L., Vite C.H., Wiemelt S., Hasson C.W., O'Malley T.M., He X., Prociuk U., Verot L., Melniczek J.R., Lannon A., Aguirre G.D., Knox V.W., Evans S.M., Vanier M.T., Schuchman E.H., Walkley S.U., and Haskins M.E. Bone marrow transplantation for feline mucopolysaccharidosis I. Mol. Genet. Metab. 91 (2007) 239-250
14. Zheng Y., Rozengurt N., Ryazantsev S., Kohn D.B., Satake N., and Neufeld E.F. Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow. Mol. Genet. Metab. 79 (2003) 233-244
15. Hobbs J.R., Hugh-Jones K., Barrett A.J., Byrom N., Chambers D., Henry K., James D.C., Lucas C.F., Rogers T.R., Benson P.F., Tansley L.R., Patrick A.D., Mossman J., and Young E.P. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2 (1981) 709-712
16. Will A., Cooper A., Hatton C., Sardharwalla I.B., Evans D.I., and Stevens R.F. Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch. Dis. Child. 62 (1987) 1044-1049
17. Schonberger S., Roerig P., Schneider D.T., Reifenberger G., Gobel U., and Gartner J. Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy. Arch. Neurol. 64 (2007) 651-657
18. Cogle C.R., Yachnis A.T., Laywell E.D., Zander D.S., Wingard J.R., Steindler D.A., and Scott E.W. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 363 (2004) 1432-1437
19. Tokimasa S., Ohta H., Takizawa S., Kusuki S., Hashii Y., Sakai N., Taniike M., Ozono K., and Hara J. Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: single-institute experience. Pediatr. Transplant. 12 (2008) 672-676
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Voznyi Y.V., Keulemans J.L., and van Diggelen O.P. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J. Inherit. Metab. Dis. 24 (2001) 675-680
22. Hindman J., and Cotlier E. Glycosidases in normal human leukocytes and abnormalities in G M1-gangliosidosis. Clin. Chem. 18 (1972) 971-975
23. Nakamura Y., Carlson M., Krapcho K., and White R. Isolation and mapping of a polymorphic DNA sequence (pMCT118) on chromosome 1p [D1S80]. Nucleic Acids Res. 16 (1988) 9364
24. Kasai K., Nakamura Y., and White R. Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J. Forensic Sci. 35 (1990) 1196-1200
25. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., and De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17 (2002) 479-489
26. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., and Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl. 1 (2004) S208-S219
27. Chen J.T., Collins D.L., Atkins H.L., Freedman M.S., Galal A., and Arnold D.L. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 66 (2006) 1935-1937
28. Yoshizumi T., Gondolesi G.E., Bodian C.A., Jeon H., Schwartz M.E., Fishbein T.M., Miller C.M., and Emre S. A simple new formula to assess liver weight. Transplant. Proc. 35 (2003) 1415-1420
29. Vedolin L., Schwartz I.V., Komlos M., Schuch A., Puga A.C., Pinto L.L., Pires A.P., and Giugliani R. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR. Am. J. Neuroradiol. 28 (2007) 1029-1033
30. Maquat L.E. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118 (2005) 1773-1776
31. Chang J.H., Lin S.P., Lin S.C., Tseng K.L., Li C.L., Chuang C.K., and Lee-Chen G.J. Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II). Hum. Genet. 116 (2005) 160-166
32. Romisch K. Endoplasmic reticulum-associated degradation. Annu. Rev. Cell Dev. Biol. 21 (2005) 435-456
33. Davoust N., Vuaillat C., Androdias G., and Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol. 29 (2008) 227-234
34. Kennedy D.W., and Abkowitz J.L. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90 (1997) 986-993
35. Ajami B., Bennett J.L., Krieger C., Tetzlaff W., and Rossi F.M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10 (2007) 1538-1543
36. McKinnis E.J., Sulzbacher S., Rutledge J.C., Sanders J., and Scott C.R. Bone marrow transplantation in Hunter syndrome. J. Pediatr. 129 (1996) 145-148
37. Resnick J.M., Krivit W., Snover D.C., Kersey J.H., Ramsay N.K., Blazar B.R., and Whitley C.B. Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation. Bone Marrow Transplant. 10 (1992) 273-280
38. Resnick J.M., Whitley C.B., Leonard A.S., Krivit W., and Snover D.C. Light and electron microscopic features of the liver in mucopolysaccharidosis. Hum. Pathol. 25 (1994) 276-286
39. Ochiai T., Ito K., Shichino H., Chin M., and Mugishima H. Ultrastructural findings of cutaneous nerves in patients with Hunter's syndrome following hematopoietic stem cell transplant. Med. Mol. Morphol. 38 (2005) 118-122
40. Shapiro E.G., Lockman L.A., Balthazor M., and Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J. Inherit. Metab. Dis. 18 (1995) 413-429
41. Malatack J.J., Consolini D.M., and Bayever E. The status of hematopoietic stem cell transplantation in lysosomal storage disease. Pediatr. Neurol. 29 (2003) 391-403
42. Krivit W. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin. Immunopathol. 26 (2004) 119-132
43. Orchard P.J., Blazar B.R., Wagner J., Charnas L., Krivit W., and Tolar J. Hematopoietic cell therapy for metabolic disease. J. Pediatr. 151 (2007) 340-346
44. Guffon N., Bertrand Y., Forest I., Fouilhoux A., and Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J. Pediatr. 154 (2009) 733-737
45. Peters C., Shapiro E.G., Anderson J., Henslee-Downey P.J., Klemperer M.R., Cowan M.J., Saunders E.F., deAlarcon P.A., Twist C., Nachman J.B., Hale G.A., Harris R.E., Rozans M.K., Kurtzberg J., Grayson G.H., Williams T.E., Lenarsky C., Wagner J.E., and Krivit W. Hurler syndrome. II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91 (1998) 2601-2608
46. Birkenmeier E.H., Barker J.E., Vogler C.A., Kyle J.W., Sly W.S., Gwynn B., Levy B., and Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78 (1991) 3081-3092
47. Yamada T., Ohyagi Y., Shinnoh N., Kikuchi H., Osoegawa M., Ochi H., Kira J., and Furuya H. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model. J. Neurol. Sci. 218 (2004) 91-97